Claudin Expression Modulations Reflect an Injury Response in the Murine Epidermis  by Arabzadeh, Azadeh et al.
Claudin Expression Modulations Reflect an Injury Response
in the Murine Epidermis
Journal of Investigative Dermatology (2008) 128, 237–240; doi:10.1038/sj.jid.5700966; published online 12 July 2007
TO THE EDITOR
The mature epidermis is maintained
throughout life in response to discrete
signals whereby epidermal cells in the
proliferative basal compartment be-
come irreversibly committed to term-
inal differentiation and move upwards
away from the basal layer to maintain a
constant thickness and homeostasis
(Turksen and Troy, 1998; Mack et al.,
2005). However, in response to injury
or in experimentally induced hyper-
plasia/tissue remodeling following the
topical application of phorbol esters
(Molloy and Laskin, 1987), epidermal
homeostasis is perturbed, resulting in
changes in epidermal terminal differ-
entiation and barrier selectivity. In vivo
studies have demonstrated that the
epidermis is characterized by a defined
differentiation-dependent expression of
Claudins (Cldns) (Turksen and Troy,
2002; Troy et al., 2005, 2007; Arabza-
deh et al., 2006), a family of tetraspan
membrane proteins that comprise a
major component of tight junction (TJ)
fibrils essential to the structure and
function of TJs (Turksen and Troy,
2004; Furuse and Tsukita, 2006; Van
Itallie and Anderson, 2006). Recent
studies have also shown that changes
in Cldns may contribute to changes
observed in cell permeability and bar-
rier selectivity (Furuse et al., 2002;
Turksen and Troy, 2002; Troy et al.,
2005). However, no systematic analysis
of Cldns during epidermal repair is yet
available.
In this study, we examined the
expression of Cldns in the mouse
epidermis during the course of 12-
O-tetradecanoyl-phorbol-13-acetate
(TPA)-induced injury, transient hyper-
proliferation, and repair. Our data indicate
that Cldns are modulated in parallel
with epidermal cell morphology and
differentiation changes in a manner
indicative of cell polarity and barrier
selectivity changes. Specifically, the
differentiation compartment-specific
Cldns occupied a broader zone of
expression, with a loss of membranous
localization. In addition to becoming
cytoplasmic, Cldn1 was downregulated
in the epidermal basal compartment
and was observed to shuttle between
the cytoplasm and the nucleus, thus
suggesting a potential molecular basis
for the changes observed in TJ modula-
tion in response to injury.
The dorsal backskin of several 1-
month-old CD1 mice was treated with
a single dose of TPA (25 mg/ml in
acetone); all animal studies were con-
ducted according to the regulations of
the Canadian Council on Animal Care.
Samples (B1 cm2) were dissected from
the mid-dorsal region of treated mice as
well as their untreated and vehicle-
treated counterparts at 4, 6, 12, 24, 48,
72, and 96 hours post-application and
processed for immunofluorescence as
described (Arabzadeh et al., 2006; Troy
et al., 2007). Histological analysis of
skin samples from TPA-treated CD-1
mice revealed expected modifications
in the morphology of the TPA-treated
epidermis (Figure 1-column 1). From
12 to 72 hours, the epidermis under-
went a gradual thickening with char-
acteristic changes in cellular morpho-
logy, including some degree of suprabasal
keratinocyte disorganization as well as
an expanded stratum corneum. The
thickening pattern and histological ab-
normalities of the treated epidermis
were not sustained and underwent
normalization commencing after
96 hours indicative of the repair me-
chanism of the epidermis.
To compliment our histological ob-
servations, immunohistochemical ana-
lyses were performed to evaluate the
expression of classical markers of the
epidermis. Beginning 12 hours after
TPA treatment, immunofluorescence
analyses revealed that K14 was loca-
lized in all the basal to suprabasal
layers, and the expression compartment
of K1 was significantly expanded (not
shown). In addition, loricrin expression
occupied a thicker zone of expression
beginning 48 hours after TPA treatment
(not shown). After 96 hours as the
epidermis underwent normalization,
so too did the expression compartments
of these markers. K6 expression, which
is generally absent in the adult wild-
type interfollicular epidermis except
under hyperproliferative conditions,
was evident 12 hours after TPA treat-
ment where its expression was main-
tained throughout the experimental
protocol, with an indication of down-
regulation evident after 96 hours (not
shown). Immunolocalization with anti-
Ki67 antibodies, a nuclear protein
expressed by proliferating cells during
all phases of the cell cycle, confirmed
the proliferation response of the TPA-
treated epidermis (Figure 1-column 2).
In addition, immunostaining for the
T-cell receptor-associated CD3 complex
indicated that from 24 to 72 hours,
there was a modest increase in the
dermal infiltration of CD3-positive
T cells that was reduced in response
to tissue repair at 96 hours (not shown).
We next analyzed by immunofluore-
scence the expression of those Cldns
we have previously demonstrated to be
important in epidermal differentiation
and the formation of the epidermal
permeability barrier (Turksen and Troy,
2002; Arabzadeh et al., 2006; Troy
et al., 2005, 2007). Commencing
12 hours after TPA application, Cldn6
(Figure 1-column 3), Cldn11 (Figure 1-
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column 4), and Cldn18 (Figure 1-
column 5) (the suprabasal cell-specific
Cldns) were expressed in an expanded
zone, where there was also a shift in
their subcellular localization from the
membrane to the cytoplasm. Transient
changes in epidermal differentiation
and proliferation resulted in reversible
Cldn expression and localization mod-
ifications, indicating that the TJ-based
permeability barrier was perturbed from
12 to 72 hours after a single epidermal
exposure to TPA, and that it was in
repair-mode by 96 hours. Although the
molecular mechanism is not known,
the role of TPA in the activation of
protein kinase C has been demonstrated
(Hennings et al., 1992) and therefore
protein kinase C may be acting indi-
rectly by changing nuclear receptors
(eg. RAR, PPAR) and/or growth factor
signaling (eg. EGF, IGF) in the epider-
mis (Kumar et al., 1994; Hatoum et al.,
2001; Stewart and O’Brian, 2005)
resulting in downstream changes affect-
ing Cldn localization. Or since the
cytoplasmic tail domain of several
Cldns contains putative protein kinase
C sites, a direct protein kinase
C-dependent phosphorylation of Cldns
may be involved in the relocalization of
Cldns from the membrane to the
cytoplasm. However, either a direct or
indirect protein kinase C-dependent
modulation of Cldn localization in the
epidermis in response to TPA is yet to
be demonstrated.
Beyond the cytoplasmic relocaliza-
tion of the suprabasal-specific Cldns,
the distribution of Cldn1 (Zymed
Laboratories Inc., San Francisco, CA;
cat. no. 71–7800) was also perturbed,
albeit in a different manner. In the
normal mature epidermis, Cldn1 occu-
pies both the basal and suprabasal
compartments as observed in the vehi-
cle-treated epidermis (Figure 2a). In
response to TPA exposure, Cldn1 ex-
pression adopted a progressively more
cytoplasmic localization as observed
from 4 to 72 hours after treatment,
especially in the lower strata of the
epidermis (Figures 2b–g). In addition,
some nuclear association was evident
from 12 to 72 hours commencing in the
basal layer and moving upwards into the
lower suprabasal layers. By 96 hours
post-treatment, the membranous basal
to suprabasal localization of Cldn1 was
mostly restored, with little cytoplasmic
and nuclear association detected indica-
tive of the normalization of the epidermis
(Figure 2h). Co-immunolocalization
using anti-Lamin B and anti-Cldn1 anti-
bodies clearly demarcates the nuclear
lamina in the cells of the epidermis, and
supports the notion of the nuclear
association of Cldn1 (Figure 2i).
Although the molecular mechanism
is not understood, it is widely recog-
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Figure 1. Morphological changes, epidermal hyperproliferation, and changes in the epidermal
expression of suprabasal-associated Cldns in response to a single exposure to TPA. Backskin samples
from CD-1 mice at (a) 4, (b) 12, (c) 24, (d) 48, (e) 72, and (f) 96 hours post-TPA-application were
compared with their acetone-treated counterparts (g) for histological changes (hematoxylin and eosin)
and epidermal proliferation was confirmed through the increased localization of Ki67-positive cells by
immunofluorescence. Immunolocalization of Cldn6, Cldn11, and Cldn18 revealed expanded epidermal
expression compartments after a single exposure to TPA. In addition, there was a shift in Cldn localization
from the membrane to the cytoplasm from 24 to 72 hours. In the repairing epidermis 96 hours after TPA
treatment, membrane localization of the suprabasal-specific Cldns was evident with an overall reduction
in the expression compartment.
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nized that TPA induces affects on the TJ
and its components (Ojakian, 1981;
Mullin and O’Brien, 1986). Specifi-
cally, a TPA-induced dislocation of
ZO-1, a TJ scaffolding molecule, has
been observed (Weiler et al., 2005). As
ZO-1 has been noted to shuttle be-
tween the cytoplasm and the nucleus
under some circumstances (Gonzalez-
Mariscal et al., 1999; Islas et al., 2002;
Riesen et al., 2002), it is interesting to
speculate that indeed a similar mecha-
nism may be acting on Cldn1. Conver-
sely, however, in the case of the
epidermis, ZO-1 is only localized in
the terminal differentiation compart-
ment (Morita et al., 1998; Arabzadeh
et al., 2006), and not in the basal and
lower suprabasal layers where we
report the TPA-depended shuttling of
Cldn1; therefore, this observed phe-
nomenon is likely not due to a Cldn1/
ZO-1 interaction. Whether Cldn1 has
nuclear export and import sequences
remains to be demonstrated, in addition
to whether or not Cldn1 interacts with
other proteins as part of its shuttling.
Given that nuclear translocation of
various membrane-associated proteins
has been demonstrated in the regula-
tion of cell proliferation and differentia-
tion, it is likely that the nuclear
association of Cldn1 has a role in the
observed epidermal response to injury;
however, the mechanism remains to be
elucidated. Collectively, our studies
provide persuasive evidence that me-
chanisms involving post-translational
and gene expression modifications are
important in the dynamic changes
occurring in Cldn expression in the
disruption and normalization of epider-
mal homeostasis.
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Figure 2. Cldn1 relocalization in response to a single application of TPA. (a) Immunofluorescence
analyses revealed that in the acetone-treated epidermis, the mature localization of Cldn1 was maintained
in the basal and suprabasal layers. Cldn1 localization was modulated as observed after (b) 4, (c) 6,
(d) 12, (e) 24, (f and i) 48, (g) 72, and (h) 96 hours in response to a single application of TPA. Cldn1
became increasingly cytoplasmic, especially in the lower strata of the epidermis where some nuclear
association was observed from 12 to 72 hours after treatment; nuclei are demarcated in (i) by
co-immunolocalization with Lamin B. By 96 hours, membrane association and localization in all strata
was indicative of epidermal normalization. Co-immunolocalization demonstrates that although Cldn1
nuclear association is evident in the basal and immediate suprabasal layers (arrows), the nuclei in the
upper strata are void (star). Please note that in (a-h) Cldn1 antigen is detected using FITC-conjugated goat
anti-rabbit antibodies (green); in (i) Cldn1 antigen is detected using Alexa Fluor 594-conjugated donkey
anti-rabbit antibodies (red) and Lamin B antigen is detected using Alexa Fluor 488-conjugated chicken
anti-goat antibodies (green).
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Alopecia areata (AA) is an organ-
specific autoimmune disease in which
T cells are directed against hair folli-
cles, causing a non-scarring alopecia
ranging from patchy AA to total scalp
(alopecia totalis (AT)), or scalp and
body hair loss (alopecia universalis
(AU)) (Gilhar and Kalish, 2006). Pre-
vious studies have shown that major
histocompatibility complex genes on
chromosome 6p21 encoding human
leukocyte antigens (HLAs) are major
determining loci for T-cell-mediated
diseases including AA (Nair et al.,
2000; Martinez-Mir et al., 2007). In
addition to HLA molecules, major
histocompatibility complex class I
chain-related gene A (MICA), a stress-
inducible antigen, is also associated
with several autoimmune diseases in-
cluding AA (Barahmani et al., 2006).
MICA is located about 46.5 kb centro-
meric to HLA-B, 1.2 Mb telomeric to the
HLA-D region with a distance between
HLA-DQB1 and DRB1 of about 65 kb
(Nair et al., 2000). Whether class I or II
HLA genes are more important for
susceptibility to AA is not yet known
and would have implications for the
pathogenesis as a CD8þ or CD4þ
T-cell-mediated disease.
We have previously reported that in
sporadic AA, HLA-DQB1*03(*0301-
*0305) alleles were present in 92% of
patients with AT/AU and in 80% of all
patients with AA. We also showed that
the frequency of the HLA-DRB1*1104
allele increased for all types of AA
((Welsh et al., 1994; Colombe et al.,
1995; Duvic et al., 1995; Price and
Colombe, 1996), whereas the frequen-
cies of HLA-DR52a (HLA-DRB3*0101)
and HLA-DQB1*06 alleles were nega-
tively associated (Duvic et al., 1991;
Welsh et al., 1994). These genes (HLA-
DQB1 and HLA-DR) were also found to
be linked to familial AA (de Andrade
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